Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $147.9600 (-0.23%) ($147.3400 - $149.6600) on Fri. Oct. 13, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.1% (three month average) | RSI | 20 | Latest Price | $147.9600(-0.23%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV declines -1.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) DIA(56%) IBB(53%) SPLV(50%) VYM(50%) | Factors Impacting ABBV price | ABBV will decline at least -0.55% in a week (0% probabilities). VXX(-37%) VIXM(-34%) USO(-26%) TBT(-22%) GLD(-22%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.55% (StdDev 1.1%) | Hourly BBV | -0.8 () | Intraday Trend | -0.7% | | | |
|
Resistance Level | $150.5 | 5 Day Moving Average | $148.72(-0.51%) | 10 Day Moving Average | $148.28(-0.22%) | 20 Day Moving Average | $150.5(-1.69%) | To recent high | -4.3% | To recent low | 10.8% | Market Cap | $261.043b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |